Companies
Viatris
PharmaceuticalsCanonsburg, PennsylvaniaVTRSMore than 30,000 employees
More about Viatris
Drugmaker that sells generic, branded and off-patent medicines in more than 165 countries
Revenue
$14.3B
Fiscal 2025, down 3%
Employees
More than 30,000
As of December 2025
Stock
VTRS
Nasdaq
Headquarters
Canonsburg, Pennsylvania
CEO
Scott A. Smith
Since April 2023
BrandsLipitor, Norvasc, Viagra, EpiPen, generics
Current strategyRestructuring after a strategic review to build a more focused, efficient company, while fixing FDA issues at its Indore, India plant
Recent workforce changesAbout 10% of its workforce to be cut over three years, announced February 2026
CompetitorsTeva, Sandoz, Hikma
Related companiesPfizerJohnson & Johnson
Checked October 11, 2026 · Sources: sec.gov, manufacturingchemist.com, biospace.com
Be the first to post about Viatris
No one has started a discussion here yet. Yours is anonymous and appears right away, and we don’t store who wrote it.
Or follow Viatris to see the first post in your watchlist.
Follow Viatris in a feed reader, no account needed: RSS feed